Founded in neuropathological expertise.
Our sophisticated diffusion analysis is based on neuropathology, and the correlations between microscopic data and MRI analysis. Based at the University of Oxford, Dr Steven Chance and Professor Mark Jenkinson combined their world class expertise to develop CDM® technology.

Today, this breakthrough technology can provide an assessment of brain health based on changes at the cellular level, for dementia patients, which previously could only be analysed at post-mortem.

Founded in neuropathological expertise.
Our sophisticated diffusion analysis is based on neuropathology, and the correlations between microscopic data and MRI analysis. Based at the University of Oxford, Dr Steven Chance and Professor Mark Jenkinson combined their world class expertise to develop CDM® technology.

Today, this breakthrough technology can provide an assessment of brain health based on changes at the cellular level, for dementia patients, which previously could only be analysed at post-mortem.

Oxford Brain Diagnostics Ltd. news

Contact supplier